AdreView and Renal impairment
Result of checking the interaction of drug AdreView and disease Renal impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Iobenguane I-123 is cleared by the kidneys and is not dialyzable. When iobenguane I-123 is used in patients with severe renal impairment, the radiation dose may be increased due to delayed elimination of the drug which may also reduce the target to background rations and decrease the quality of scintigraphic images. Care should be exercised when using this agent in patients with severe renal impairment as the safety and efficacy have not been established in these patients. It is recommended to consider assessment of renal function in patients prior to iobenguane I-123 administration.